**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 529-20-4 |O-Tolualdehyde, Stabilized with 0.1% H| 98% | 208-452-2 |
| |ydroquinone | | |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully
investigated.
Potential Health Effects
Eye:
May cause eye irritation. May cause chemical conjunctivitis and
corneal damage.
Skin:
May cause irritation and dermatitis. May cause cyanosis of the
extremities.
Ingestion:
May cause irritation of the digestive tract. May cause
gastrointestinal irritation with nausea, vomiting and diarrhea. The
toxicological properties of this substance have not been fully
investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties
of this substance have not been fully investigated. Aspiration may
lead to pulmonary edema. Inhalation at high concentrations may cause
CNS depression and asphixiation.
Chronic:
Effects may be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing
is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation. If breathing has ceased apply artificial respiration
using oxygen and a suitable mechanical device such as a bag and a
mask.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use water
spray to keep fire-exposed containers cool. Combustible liquid.
Vapors may be heavier than air. They can spread along the ground and
collect in low or confined areas. Containers may explode when heated.
Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
Use water spray to cool fire-exposed containers. Use agent most
appropriate to extinguish fire. Use water spray, dry chemical,
carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Remove all
sources of ignition. Use a spark-proof tool. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use only in a well-ventilated area. Avoid contact
with eyes, skin, and clothing. Empty containers retain product
residue, (liquid and/or vapor), and can be dangerous. Keep container
tightly closed. Keep away from heat, sparks and flame. Avoid
ingestion and inhalation. Do not pressurize, cut, weld, braze,
solder, drill, grind, or expose empty containers to heat, sparks or
open flames.
Storage:
Keep away from sources of ignition. Keep container closed when not
in use. Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 529-20-4:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves and clothing to
prevent skin exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: clear yellow
Odor: None reported.
pH: Not available.
Vapor Pressure: 3 hPa @ 50 C
Viscosity: Not available.
Boiling Point: 199 - 200 deg C @ 760.00mmHg
Freezing/Melting Point: -35 deg C
Autoignition Temperature: 375 deg C ( 707.00 deg F)
Flash Point: 67 deg C ( 152.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: slightly soluble
Specific Gravity/Density: 1.0390g/cm3
Molecular Formula: C8H8O
Molecular Weight: 120.15
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, ignition sources, excess heat, strong
oxidants.
Incompatibilities with Other Materials:
Oxidizing agents, strong bases, strong reducing agents.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon
dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 529-20-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
O-Tolualdehyde, Stabilized with 0.1% Hydroquinone -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 529-20-4: 2
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 529-20-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 529-20-4 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #5 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
l-Cysteic Acid Monohydrate, 99+%
| 23537-25-9 |
|
1-Hexanesulfonic acid sodium salt premixed concentrate
| |
|
N-Alpha-Carbobenzyloxy-L-Asparagine, 98%
| 2304-96-3 |
|
Ytterbium atomic absorption standard solution, 1 mg/ml yb in 2% hno3
| |
|
Bromotrichloromethane, 99%
| 75-62-7 |
|
Dicyclopentadiene, 95%, stabilized with 100-200 ppm
| 77-73-6 |
|
3-Amino-1-propanesulfonic acid, 95%
| 3687-18-1 |
|
Copper(ii) fluoride, anhydrous, 99+%
| 7789-19-7 |
|
2-Chloro-4-Fluorophenylacetic Acid
| 177985-32-9 |
|
Cyclopropyl Phenyl Sulfide
| 14633-54-6 |
|
BOC-L-Tyrosine, 99+%
| 3978-80-1 |
|
1,8-Octanediol, 99+%
| 629-41-4 |
|
3-Thiophenecarboxylic acid, 99%
| 88-13-1 |
|
1,2,3-Trimethylbenzene, Tech., 90%
| 526-73-8 |
|
Molybdenum(v) chloride, 98%
| 10241-05-1 |
|
2-Dimethylaminoethyl Acetate
| 1421-89-2 |
|
4-Benzyl-4-Hydroxypiperidine, 95+%(GC)
| 51135-96-7 |
|
8-Chloroquinoline, 99% (gc)
| 611-33-6 |
|
2-Ethyl-3,5(6)-dimethylpyrazine,99.5+%
| 27043-05-6 |
|
p-Ethoxybenzyl Alcohol, 98%
| 6214-44-4 |
|
2,3-Dichlorothiophene, 97%
| 17249-79-5 |
|
Tropolone, 98%
| 533-75-5 |
|
1,3-Difluorobenzene, 99+%
| 372-18-9 |
|
2-Methylundecanal, 95%
| 110-41-8 |
|
2-Ethyl-2-methyl-1,3-dioxolane, 99%
| 126-39-6 |
|
Bromoethane, 98%
| 74-96-4 |
|
1,3,5-Triphenylbenzene, 97%
| 612-71-5 |
|
1-Tetradecene, 92%
| 1120-36-1 |
|
9,10-Anthracenedicarboxaldehyde, 95% (UV-Vis)
| 7044-91-9 |
|
Lead cyclohexanebutyrate
| 62637-99-4 |
|
1-Butanethiol, 99+%
| 109-79-5 |
|
L-(+)-Homoarginine hydrochloride, 99+%
| 1483-01-8 |
|
3,4-(Methylenedioxy)-aniline, 97%
| 14268-66-7 |
|
(2-Chloroethyl)benzene, 99%
| 622-24-2 |
|
Poly(propylene), chlorinated
| 68442-33-1 |
|
Dodecyl aldehyde, 96%, stabilized with 0.1% BHA
| 112-54-9 |
|
N,N'-Diallyltartardiamide
| 58477-85-3 |
|
5,6,7,8-Tetrahydro-2-naphthol, 98%
| 1125-78-6 |
|
Cyclodecanone, 97%
| 1502-06-3 |
|
4-Amino-1-butanol, 98%
| 13325-10-5 |
|
4-Aminoveratrole, 98%
| 6315-89-5 |
|
2-Bromo-4-nitrotoluene, 98%
| 7745-93-9 |
|
Pulegone (Pract), 88% (GC)
| 89-82-7 |
|
Diethyl suberate, 98%
| 2050-23-9 |
|
beta-Bromostyrene, mixture of cis/trans isomers, 97%
| 103-64-0 |
|
Naphthenic acids (pract)
| 1338-24-5 |
|
S(+)-1,3-Butanediol, 98%
| 24621-61-2 |
|
5-Bromo-1,2,4-trimethylbenzene, 99%
| 5469-19-2 |
|
alpha-D(+)-Melibiose hydrate, 99+%
| 585-99-9 |
|
O-Tolualdehyde 98% (Stabilized with 0.1 % H.Q.)
| 529-20-4 |
|
|